Gepotidacin not checked

GSK · GSK2140944

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 1 trial completes
Trials
2 active
10 in total · 1 in the EU

What this is

How it works
Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor FDA class
How it’s given
“A single oral dose of 3000 mg gepotidacin will be administered”In the company’s words, NCT07645235 on ClinicalTrials.gov
Tested for
Urinary Tract Infections (2 trials)
Main trialPhase 1
“This study aims to evaluate the pharmacokinetic of gepotidacin in fed healthy lactating women.”In the company’s words, NCT07645235 on ClinicalTrials.gov
Other names
GSK2140944

Other drugs for Urinary Tract Infections

All 5 drugs for Urinary Tract Infections

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials10

TrialPhaseCompletesWhat it tests
Phase 1Recruiting 17 May 2027 A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women
Phase 1Not yet recruiting 23 Aug 2027 A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
Phase 3Completed 30 Nov 2022 A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
Phase 3Completed 1 Dec 2022 Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
Phase 3Completed 10 Oct 2023 A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
Phase 3Completed 2 Feb 2024 A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)
Phase 3Completed 10 Mar 2025 A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)
Phase 1Completed 26 Dec 2018 Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function
Phase 1Completed 21 Dec 2020 Drug-drug Interaction Study of Gepotidacin
Phase 1Completed 22 Apr 2022 A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Gepotidacin

Following is part of Solo: you see every change to Gepotidacin the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in